title: Zolmitriptan and human aggression: interaction with alcohol.
abstract: BACKGROUND
  The serotonin 1(B/D) (5-HT1(B/D)) receptor has shown potential as a target for decreasing aggression. The 5-HT1(B/D) agonist zolmitriptan's ability to reduce aggressive behavior in humans and its interaction with the well-known aggression-enhancing drug alcohol were examined.
  
  
  OBJECTIVE
  Our objective was to investigate zolmitriptan's potential to modify human aggression in a laboratory paradigm across a range of alcohol doses. Alcohol has been consistently associated with aggression and violence, thus we hoped to expand current understanding of alcohol's role in aggressive behavior via manipulation of the serotonin (5-HT) system.
  
  
  METHODS
  Eleven social drinkers, seven male, were recruited to participate in a research study lasting 3-4 weeks. Aggression was measured using the point-subtraction aggression paradigm (PSAP), a laboratory model widely used in human aggression studies. Subjects were administered 5-mg zolmitriptan and placebo capsules along with alcohol doses of 0.0, 0.4 and 0.8 g/kg in a within-subject, counterbalanced dosing design. Data were analyzed as the ratio of aggressive/monetary-earning responses, to account for possible changes in overall motor function due to alcohol.
  
  
  RESULTS
  There was a significant alcohol by zolmitriptan interaction on the aggressive/monetary response ratio. Specifically, compared to placebo, zolmitriptan decreased the aggressive/monetary ratio at the 0.4- and 0.8-g/kg alcohol doses.
  
  
  CONCLUSIONS
  A 5-mg dose of zolmitriptan effectively reduced alcohol-related aggression in an acute dosing protocol, demonstrating an interaction of 5-HT and alcohol in human aggressive behavior.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center Houston, Houston, TX, USA.
authors.forename: Joshua L
authors.initials: JL
authors.lastname: Gowin
authors.forename: Alan C
authors.initials: AC
authors.lastname: Swann
authors.forename: F Gerard
authors.initials: FG
authors.lastname: Moeller
authors.forename: Scott D
authors.initials: SD
authors.lastname: Lane
mesh_terms: D000328:Adult; D000374:Aggression / Q000187:drug effects*; D001944:Breath Tests / Q000379:methods; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D000431:Ethanol / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D023303:Oxazolidinones / Q000494:pharmacology*; D010919:Placebos; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D014363:Tryptamines / Q000494:pharmacology*
chemical_list: D023303:Oxazolidinones; D010919:Placebos; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan; D000431:Ethanol
references.citation: Arch Gen Psychiatry. 1998 Nov;55(11):989-94
references.pmid: 9819067
references.citation: Fundam Clin Pharmacol. 2007 Jun;21(3):265-72
references.pmid: 17521295
references.citation: Psychopharmacology (Berl). 2004 Nov;176(3-4):451-8
references.pmid: 15160265
references.citation: J Stud Alcohol. 1996 Mar;57(2):178-86
references.pmid: 8683967
references.citation: Psychopharmacology (Berl). 1999 Oct;146(4):440-6
references.pmid: 10550494
references.citation: Cell Mol Neurobiol. 2008 Nov;28(7):1017-25
references.pmid: 18425575
references.citation: Psychopharmacology (Berl). 2002 Jan;159(3):266-74
references.pmid: 11862359
references.citation: Psychopharmacology (Berl). 2001 Sep;157(2):131-41
references.pmid: 11594437
references.citation: Psychopharmacology (Berl). 2001 Aug;156(4):477-80
references.pmid: 11498726
references.citation: J Stud Alcohol. 1985 Jul;46(4):321-8
references.pmid: 4033132
references.citation: Alcohol Alcohol. 1998 Jan-Feb;33(1):47-54
references.pmid: 9539177
references.citation: Psychopharmacology (Berl). 1996 Jul;126(2):97-103
references.pmid: 8856827
references.citation: Sci Signal. 2008 Jul 15;1(28):re7
references.pmid: 18632551
references.citation: Psychopharmacology (Berl). 1995 Jun;119(4):353-60
references.pmid: 7480513
references.citation: Alcohol Clin Exp Res. 1998 Dec;22(9):1898-902
references.pmid: 9884131
references.citation: Alcohol Alcohol. 1991;26(1):71-9
references.pmid: 1854375
references.citation: Psychiatry Res. 1979 Oct;1(2):131-9
references.pmid: 95232
references.citation: J Subst Abuse. 2001;13(4):563-81
references.pmid: 11775083
references.citation: Clin Psychol Rev. 2009 Aug;29(6):506-18
references.pmid: 19573964
references.citation: Psychopharmacology (Berl). 1999 Oct;146(4):473-81
references.pmid: 10550498
references.citation: Alcohol Res Health. 2001;25(1):20-31
references.pmid: 11496963
references.citation: Arch Gen Psychiatry. 1979 Feb;36(2):224-7
references.pmid: 420544
references.citation: Alcohol Clin Exp Res. 2003 Dec;27(12):1944-54
references.pmid: 14691382
references.citation: Psychol Rep. 1966 Feb;18(1):163-94
references.pmid: 5908477
references.citation: Clin Pharmacol Ther. 1971 Mar-Apr;12(2):245-58
references.pmid: 5554941
references.citation: Recent Dev Alcohol. 1997;13:227-43
references.pmid: 9122497
references.citation: Eur J Pharmacol. 2005 Dec 5;526(1-3):207-17
references.pmid: 16310769
references.citation: Psychopharmacology (Berl). 2004 Feb;172(1):68-77
references.pmid: 14647967
references.citation: Psychopharmacology (Berl). 1999 Oct;146(4):391-9
references.pmid: 10550489
references.citation: Neuropsychopharmacology. 2008 Nov;33(12):2888-99
references.pmid: 18305458
references.citation: Psychopharmacology (Berl). 2002 Oct;163(3-4):434-58
references.pmid: 12373445
references.citation: Behav Cogn Neurosci Rev. 2003 Sep;2(3):179-97
references.pmid: 15006292
references.citation: Clin Drug Investig. 2005;25(3):199-208
references.pmid: 17523769
references.citation: Psychol Sci. 2009 Jun;20(6):714-20
references.pmid: 19422623
references.citation: Psychol Bull. 1996 Jul;120(1):60-82
references.pmid: 8711017
references.citation: Psychoneuroendocrinology. 2008 Aug;33(7):897-908
references.pmid: 18657368
references.citation: Eur J Pharmacol. 2005 Dec 5;526(1-3):51-64
references.pmid: 16325649
references.citation: Drug Alcohol Depend. 1997 Jun 6;46(1-2):95-103
references.pmid: 9246557
references.citation: Psychoneuroendocrinology. 2009 May;34(4):561-70
references.pmid: 19054624
references.citation: J Clin Psychopharmacol. 2003 Jun;23(3):269-80
references.pmid: 12826989
references.citation: Trends Pharmacol Sci. 1992 Feb;13(2):69-75
references.pmid: 1561716
references.citation: Alcohol Clin Exp Res. 2009 Apr;33(4):581-90
references.pmid: 19183141
references.citation: Exp Clin Psychopharmacol. 1997 Feb;5(1):28-38
references.pmid: 9234037
references.citation: J Psychiatr Res. 2009 Aug;43(12):1036-48
references.pmid: 19232640
references.citation: J Pharmacokinet Pharmacodyn. 2006 Feb;33(1):75-91
references.pmid: 16402287
references.citation: Am J Psychiatry. 2008 Apr;165(4):429-42
references.pmid: 18346997
references.citation: Neuroscience. 1994 Jan;58(1):167-82
references.pmid: 8159291
references.citation: Exp Clin Psychopharmacol. 2009 Jun;17(3):154-64
references.pmid: 19586230
references.citation: Violence Vict. 2007;22(1):95-103
references.pmid: 17390565
references.citation: Psychopharmacology (Berl). 2001 Sep;157(3):221-7
references.pmid: 11605076
references.citation: Exp Clin Psychopharmacol. 2009 Dec;17(6):445-55
references.pmid: 19968409
references.citation: Am J Psychiatry. 2001 Nov;158(11):1783-93
references.pmid: 11691682
references.citation: Psychopharmacology (Berl). 1999 Feb;142(2):144-8
references.pmid: 10102766
references.citation: Psychopharmacology (Berl). 2006 May;185(4):441-50
references.pmid: 16550387
references.citation: Expert Opin Drug Metab Toxicol. 2007 Dec;3(6):899-911
references.pmid: 18028032
references.citation: J Pers Soc Psychol. 1976 Nov;34(5):938-41
references.pmid: 993987
references.citation: J Stud Alcohol. 2005 Nov;66(6):815-24
references.pmid: 16459943
references.citation: Psychiatry Res. 2007 Jan 15;149(1-3):201-13
references.pmid: 17129610
references.citation: Neuropsychopharmacology. 1999 Aug;21(2):238-46
references.pmid: 10432472
references.citation: Adv Exp Med Biol. 1999;467:57-65
references.pmid: 10721038
references.citation: Psychol Med. 1996 Mar;26(2):323-31
references.pmid: 8685288
references.citation: Life Sci. 2004 Nov 19;76(1):1-8
references.pmid: 15501475
references.citation: Psychopharmacology (Berl). 2008 Dec;201(2):237-48
references.pmid: 18688602
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):129-39
references.pmid: 14687867
references.citation: Biol Psychiatry. 1997 Mar 1;41(5):514-22
references.pmid: 9046983
references.citation: Biol Psychiatry. 2007 Apr 15;61(8):974-8
references.pmid: 17217931